Header Logo

Kimberly Lenz

Concepts (82)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
353
0.700
 Why?
Analgesics, Opioid
4
2019
487
0.600
 Why?
Pain
3
2019
397
0.580
 Why?
Medication Therapy Management
3
2018
21
0.390
 Why?
Antiviral Agents
3
2018
313
0.330
 Why?
Practice Patterns, Physicians'
5
2019
693
0.320
 Why?
Hepatitis C
2
2016
143
0.230
 Why?
United States
10
2019
7432
0.170
 Why?
Drug Utilization Review
2
2017
52
0.170
 Why?
Chloride Channel Agonists
1
2019
3
0.160
 Why?
Aminophenols
1
2019
4
0.160
 Why?
Drug and Narcotic Control
2
2017
28
0.160
 Why?
Benzodioxoles
1
2019
13
0.160
 Why?
Aminopyridines
1
2019
31
0.160
 Why?
Quinolones
1
2019
27
0.160
 Why?
Cystic Fibrosis
1
2019
110
0.150
 Why?
Uridine Monophosphate
1
2018
8
0.150
 Why?
Fluorenes
1
2018
13
0.150
 Why?
Medication Adherence
2
2017
241
0.150
 Why?
Benzimidazoles
1
2018
54
0.140
 Why?
Psychotropic Drugs
1
2018
81
0.140
 Why?
Insurance, Pharmaceutical Services
2
2014
19
0.140
 Why?
Hydrocodone
1
2017
6
0.140
 Why?
Hepatitis C, Chronic
1
2018
88
0.140
 Why?
Opioid-Related Disorders
2
2014
457
0.140
 Why?
Drug Prescriptions
1
2018
168
0.140
 Why?
Hepacivirus
1
2018
140
0.130
 Why?
Progesterone
1
2017
158
0.130
 Why?
Premature Birth
1
2017
108
0.130
 Why?
Prescription Drug Diversion
1
2014
7
0.110
 Why?
Lung
1
2019
920
0.110
 Why?
State Government
1
2014
29
0.110
 Why?
Prescription Drug Misuse
1
2014
20
0.110
 Why?
Drug Combinations
3
2019
147
0.110
 Why?
Drug Interactions
1
2014
115
0.110
 Why?
Managed Care Programs
1
2014
88
0.110
 Why?
Retrospective Studies
7
2018
6079
0.100
 Why?
Health Services Accessibility
1
2016
527
0.090
 Why?
Mental Disorders
1
2018
720
0.090
 Why?
Treatment Outcome
3
2016
5287
0.080
 Why?
Young Adult
4
2019
4274
0.070
 Why?
Adolescent
4
2019
5851
0.070
 Why?
Adult
6
2019
15697
0.070
 Why?
Humans
10
2019
59454
0.070
 Why?
Drug Costs
2
2016
54
0.060
 Why?
Cost Savings
2
2016
54
0.060
 Why?
Female
7
2019
30766
0.060
 Why?
Cost-Benefit Analysis
2
2017
299
0.060
 Why?
Middle Aged
5
2019
16335
0.060
 Why?
Program Evaluation
2
2018
470
0.060
 Why?
Pharmacists
2
2016
123
0.050
 Why?
Male
6
2019
27784
0.050
 Why?
Massachusetts
2
2018
2022
0.050
 Why?
Cohort Studies
2
2017
2377
0.040
 Why?
Child
2
2019
4201
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
74
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
18
0.040
 Why?
Ribavirin
1
2018
24
0.040
 Why?
Polypharmacy
1
2018
61
0.040
 Why?
Treatment Failure
1
2018
185
0.040
 Why?
Hydroxyprogesterones
1
2017
6
0.040
 Why?
Viral Load
1
2018
220
0.040
 Why?
Controlled Substances
1
2017
5
0.040
 Why?
Dose-Response Relationship, Drug
1
2019
805
0.030
 Why?
RNA, Viral
1
2018
259
0.030
 Why?
Drug Therapy, Combination
1
2018
451
0.030
 Why?
Gestational Age
1
2017
180
0.030
 Why?
Psychiatry
1
2018
114
0.030
 Why?
Genotype
1
2018
619
0.030
 Why?
Insurance Claim Review
1
2016
76
0.030
 Why?
Evidence-Based Medicine
1
2018
443
0.030
 Why?
Pregnancy Outcome
1
2017
181
0.030
 Why?
Government Regulation
1
2014
40
0.030
 Why?
Interdisciplinary Communication
1
2014
104
0.030
 Why?
Physician's Role
1
2014
120
0.030
 Why?
Cooperative Behavior
1
2014
210
0.020
 Why?
Health Policy
1
2014
177
0.020
 Why?
Mutation
1
2019
2458
0.020
 Why?
Pregnancy
1
2017
2215
0.020
 Why?
Time Factors
1
2014
3621
0.020
 Why?
Aged
1
2018
13424
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_